Skip to main content
Oncology Peer Review On-The-Go: 1-on-1 with David Johnson: Enveric’s Endocannabinoid Products for Glioblastoma [Cancer Network]
https://www.cancernetwork.com/view/oncology-peer-review-on-the-go-1-on-1-with-david-johnson-enveric-s-endocannabinoid-products-for-glioblastoma
Enveric Biosciences Signs Licensing Agreement with Diverse Biotech [Pharmaceutical Business Review]
https://www.pharmaceutical-business-review.com/news/enveric-biosciences-signs-licensing-agreement-with-diverse-biotech/
Enveric Biosciences Acquires License for Diverse Biotech’s Novel Molecules [Pharmaceutical Technology]
https://www.pharmaceutical-technology.com/news/enveric-acquires-diverse-molecules/
Enveric Biosciences Stock Skyrockets After Licensing Agreement With Diverse Biotech [Benzinga]
https://www.benzinga.com/general/biotech/21/03/20098291/enveric-biosciences-stock-skyrockets-after-licensing-agreement-with-diverse-biotech
CBD-focused Enveric Biosciences Stock Soars on Heavy Volume After License Deal with Cancer Treatment Company [Market Watch]
https://www.marketwatch.com/story/cbd-focused-enveric-biosciences-stock-soars-on-heavy-volume-after-license-deal-with-cancer-treatment-company-2021-03-10
Rising High: An Exclusive Talk with Biotech Company Enveric Biosciences [The Fly]
https://thefly.com/landingPageNews.php?id=3246224
